Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis-Reference-Cited by-同舟云学术

Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis

Published:2009-12 Issue:12 Volume:100 Page:2318-2324
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Amano Hideki,Ito Yoshiya,Suzuki Tastunori,Kato Shintaro,Matsui Yoshio,Ogawa Fumihiro,Murata Takahiko,Sugimoto Yukihiko,Senior Robert,Kitasato Hidero,Hayashi Izumi,Satoh Yukitoshi,Narumiya Shuh,Majima Masataka

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2009.01322.x/fullpdf

Reference33 articles.

1. The implication of angiogenesis for the biology and therapy of cancer metastasis;Filder;Cell,1994

2. Matrix metalloproteinase in cancer: from new function to improved inhibition strategies;Folgueras;Int J Dev Biol,2004

3. Colorectal cancer and non-steroidal anti-inflammatory drugs;Smalley;Adv Pharmacol,1997

4. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential;Tsujii;Proc Natl Acad Sci USA,1997

5. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model;Narayanan;Clin Cancer Res,2004

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4;Pharmacological Reviews;2024-03-04

2. COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers;Medical Oncology;2024-01-02

3. Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy;Diabetologia;2023-08-19

4. Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics;Frontiers in Pharmacology;2022-12-05

5. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options;Experimental and Molecular Pathology;2022-10